United States: DEA Publishes Temporary Rule On The Extension Of COVID-19 Telemedicine Flexibilities For Prescription Of Controlled Substances - Goodwin Procter LLP

Mondaq

23 May 2023 0 shares 2 views

United States: DEA Publishes Temporary Rule On The Extension Of COVID-19 Telemedicine Flexibilities For Prescription Of Controlled Substances - Goodwin Procter LLP

Mondaq

Published 23 May 2023

Since the declaration of the public health emergency due to the COVID-19 epidemic, Drug Enforcement Administration registered practitioners have been able to prescribe controlled substances ...

Full Article

United States: DEA Issues Statement On Continuing PHE Telehealth Prescribing Flexibilities Beyond May 11 - Manatt, Phelps & Phillips LLP

On May 3, the Drug Enforcement Administration (DEA) issued a statement from Administrator Anne Milgram on COVID-19 telemedicine..

Mondaq 27 May 2023

United States: DEA Publishes Temporary Rule On The Extension Of COVID-19 Telemedicine Flexibilities For Prescription Of Controlled Substances - Goodwin Procter LLP

United States: DEA Publishes Temporary Rule On The Extension Of COVID-19 Telemedicine Flexibilities For Prescription Of Controlled Substances - Goodwin Procter LLP

You might like

Related news coverage

United States: DEA Issues Statement On Continuing PHE Telehealth Prescribing Flexibilities Beyond May 11 - Manatt, Phelps & Phillips LLP

Advertisement